Assembly Biosciences's total assets for Q1 2025 were $99.02M, a decrease of -16.91% from the previous quarter. ASMB total liabilities were $71.88M for the fiscal quarter, a -16.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.